METiS Pharmaceuticals (剂泰医药) is an innovative biopharmaceutical company combining artificial intelligence with drug-delivery technology to develop therapeutic candidates. Its core focus is building an AI+drug-delivery platform and advancing internally developed pipeline assets. The company announced completion of a $100 million Series C financing. Proceeds from the round will be used primarily to continue building the AI+drug-delivery platform and to further develop its self‑developed pipeline. The financing is intended to accelerate the company’s R&D and platform development efforts.

Total raised

$100M

Funding rounds

1

Latest round

Series C

Latest activity

Jun 2024